Emerging Microbes and Infections (Jan 2020)

Susceptibility of swine cells and domestic pigs to SARS-CoV-2

  • David A. Meekins,
  • Igor Morozov,
  • Jessie D. Trujillo,
  • Natasha N. Gaudreault,
  • Dashzeveg Bold,
  • Mariano Carossino,
  • Bianca L. Artiaga,
  • Sabarish V. Indran,
  • Taeyong Kwon,
  • Velmurugan Balaraman,
  • Daniel W. Madden,
  • Heinz Feldmann,
  • Jamie Henningson,
  • Wenjun Ma,
  • Udeni B. R. Balasuriya,
  • Juergen A. Richt

DOI
https://doi.org/10.1080/22221751.2020.1831405
Journal volume & issue
Vol. 9, no. 1
pp. 2278 – 2288

Abstract

Read online

ABSTRACTThe emergence of SARS-CoV-2 has resulted in an ongoing global pandemic with significant morbidity, mortality, and economic consequences. The susceptibility of different animal species to SARS-CoV-2 is of concern due to the potential for interspecies transmission, and the requirement for pre-clinical animal models to develop effective countermeasures. In the current study, we determined the ability of SARS-CoV-2 to (i) replicate in porcine cell lines, (ii) establish infection in domestic pigs via experimental oral/intranasal/intratracheal inoculation, and (iii) transmit to co-housed naïve sentinel pigs. SARS-CoV-2 was able to replicate in two different porcine cell lines with cytopathic effects. Interestingly, none of the SARS-CoV-2-inoculated pigs showed evidence of clinical signs, viral replication or SARS-CoV-2-specific antibody responses. Moreover, none of the sentinel pigs displayed markers of SARS-CoV-2 infection. These data indicate that although different porcine cell lines are permissive to SARS-CoV-2, five-week old pigs are not susceptible to infection via oral/intranasal/intratracheal challenge. Pigs are therefore unlikely to be significant carriers of SARS-CoV-2 and are not a suitable pre-clinical animal model to study SARS-CoV-2 pathogenesis or efficacy of respective vaccines or therapeutics.

Keywords